Avantor (NYSE: AVTR) Securities Class Action: Johnson Fistel Reminds Investors of December 29 Deadline to Seek Lead Plaintiff Appointment

(NYSE:AVTR), SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (NYSE: AVTR) common stock during the period between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). The lawsuit seeks to […]

Repairon Announces Positive Clinical Outcomes of Engineered Heart Muscle as Reparative Therapy for Advanced Heart Failure Reported at the Scientific Sessions of the American Heart Association

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) transplants in patients with advanced heart failure. Wolfram Zimmermann, MD, professor and director of the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen, Germany,

Avantor (NYSE: AVTR) Securities Class Action: Johnson Fistel Reminds Investors of December 29 Deadline to Seek Lead Plaintiff Appointment

Avantor (NYSE: AVTR) Securities Class Action: Johnson Fistel Reminds Investors of December 29 Deadline to Seek Lead Plaintiff Appointment GlobeNewswire November 11, 2025 SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (NYSE:

New Jersey Jackals Announce New Ownership Under Paterson native and U.S. Army Veteran Baye Adofo-Wilson

Adofo-Wilson adds the Jackals to Hinchcliffe Sports Partners LLC, co-developer of Historic Hinchliffe Stadium & Majority Owner of the New York Cosmos The New Jersey Jackals are entering a new era of leadership and community engagement under the ownership of Baye Adofo-Wilson, co-developer of the newly restored Hinchliffe Stadium and majority owner of the New

VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authorization to deliver secure, scalable telehealth services to federal agencies and beyond. In a bold step forward, VSee is integrating advanced robotic assistance into intensive care units (ICUs),

EMCD Launches Global Crypto Payment Card, Enabling Everyday Spending Anywhere Mastercard Is Accepted

EMCD Launches Global Crypto Payment Card, Enabling Everyday Spending Anywhere Mastercard Is Accepted EMCD expands its ecosystem with a free-to-issue USDT Payment Card supporting online and in-store purchases, including through Apple Pay and Google Pay GlobeNewswire November 11, 2025 HONG KONG, Nov. 11, 2025 (GLOBE NEWSWIRE) — EMCD, a global crypto-fintech platform and one of

Jasper Therapeutics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – JSPR

(NASDAQ:JSPR), LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Jasper Therapeutics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – JSPR

Jasper Therapeutics, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – JSPR GlobeNewswire November 11, 2025 LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) for violations

DXCM INVESTORS: DexCom, Inc. Hit with Securities Class Action after 20% Stock Drop – Contact BFA Law by December 26 Court Deadline

(NASDAQ:DXCM), NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities

Scroll to Top